WW WW International Inc.

WW International, Inc. Schedules Investor Conference Call

WW International, Inc. Schedules Investor Conference Call

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, announced that it will host an investor conference call today May 6, 2025, at 6:00 p.m. ET. During the call, Tara Comonte, President and Chief Executive Officer, and Felicia DellaFortuna, Chief Financial Officer, will discuss an agreement with the Company’s lenders and noteholders that will significantly reduce debt obligations that is currently expected to result in a voluntary prepackaged filing under Chapter 11 of the U.S. Bankruptcy Code. The webcast of the conference call will be available on the Company’s corporate website, , under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days.

About WW International, Inc.

WeightWatchers is the global leader in science-backed weight management, providing an accessible, holistic model of care through our #1 doctor-recommended Points® Program, clinical interventions including weight-loss medications, and community support. Since 1963, we have empowered our millions of members to build healthy habits to live longer lives. Our innovative, trusted spectrum of solutions provides members with the tools and resources they need to reach and sustain their goals wherever they are on their journey. To learn more visit or .  

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review the Company's filings with the United States Securities and Exchange Commission (which are available on the SEC's EDGAR database at  and via the Company's website at ).

For more information, contact:

Investors:

John Mills or Anna Kate Heller

Media:

Mari Santana



EN
06/05/2025

Underlying

WWWW International Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on WW International Inc.

 PRESS RELEASE
Free
WW WW Internationa...

WeightWatchers Takes Strategic Action to Eliminate $1.15 Billion of De...

WeightWatchers Takes Strategic Action to Eliminate $1.15 Billion of Debt, Strengthening Financial Position for Long-Term Growth and Profitability Operations continue with no impact to its more than three million members worldwide Positions the Company to execute its transformation strategy, focused on enhancing its digital and member experience and expanding its telehealth business which achieved 57% year-over-year revenue growth in Q1 2025 Enters comprehensive agreement with lenders and noteholders to significantly reduce its debt obligations and bolster financial flexibility ...

May 6, 2025 1 EN
 PRESS RELEASE
Free
WW WW Internationa...

WW International, Inc. Schedules Investor Conference Call

WW International, Inc. Schedules Investor Conference Call NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, announced that it will host an investor conference call today May 6, 2025, at 6:00 p.m. ET. During the call, Tara Comonte, President and Chief Executive Officer, and Felicia DellaFortuna, Chief Financial Officer, will discuss an agreement with the Company’s lenders and noteholders that will significantly reduce debt obligations that is currently expected to result...

May 6, 2025 1 EN
 PRESS RELEASE
Free
WW WW Internationa...

WW International, Inc. Announces First Quarter 2025 Results

WW International, Inc. Announces First Quarter 2025 Results Total End of Period Subscribers of 3.4 million, including 135 thousand End of Period Clinical SubscribersRevenues of $186.6 million, down 9.7% vs. prior year period, including Clinical Subscription Revenues of $29.5 million, up 57.1% vs. prior year periodSubscription Revenues Per Paid Weeks up 4.8% vs. prior year periodGross Margin of 71.2%, up 450 basis points vs. prior year period; Adjusted Gross Margin of 71.0%, up 311 basis points vs. prior year periodNet Loss of $72.6 million; Net Loss Margin of 38.9%, improved from Net Loss M...

May 6, 2025 1 EN
 PRESS RELEASE
Free
WW WW Internationa...

WeightWatchers Streamlines Member Access to Zepbound® Vials with Lilly...

WeightWatchers Streamlines Member Access to Zepbound® Vials with LillyDirect® Pharmacy Provider New Integration with Gifthealth Simplifies Fulfillment and Medication Visibility for WeightWatchers Clinic Members NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”), the global leader in science-backed weight management, today announced a pharmacy integration with Eli Lilly and Company’s LillyDirect® pharmacy provider, . The integration will streamline access to Lilly’s FDA-approved Zepbound® (tirzepatide) single-dose vials for WeightWatcher...

April 29, 2025 1 EN
 PRESS RELEASE
Free
WW WW Internationa...

WW International, Inc. Announces Fourth Quarter and Full Year 2024 Res...

WW International, Inc. Announces Fourth Quarter and Full Year 2024 Results Fourth Quarter 2024 Financial Highlights Total End of Period Subscribers of 3.3 million, including 92 thousand End of Period Clinical SubscribersRevenues of $184.4 million; Subscription Revenues down 7.3% vs. prior year period, including Clinical Subscription Revenues of $20.5 million, up 57.9% vs. prior year periodGross Margin of 69.7%, up 906 basis points vs. prior year period; Adjusted Gross Margin of 69.1%, up 771 basis points vs. prior year periodOperating Income of $36.2 million; Operating Income Margin of 19....

February 27, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch